Incidence and significance of venous thromboembolism in critically ill pulmonary tuberculosis patients

Eur Respir J. 2020 Dec 24;56(6):2001753. doi: 10.1183/13993003.01753-2020. Print 2020 Dec.

Authors

Angela Lau¹, Wendy Sligl², Ken Sun¹, James Barrie³, Richard Long¹

Affiliations

¹ Dept of Medicine, University of Alberta, Edmonton, AB, Canada.
² Dept of Critical Care Medicine, University of Alberta, Edmonton, AB, Canada.
³ Dept of Radiology and Diagnostic Imaging, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.

PMID: 32586889
DOI: 10.1183/13993003.01753-2020

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants
Critical Illness
Humans
Incidence
Pulmonary Embolism* / epidemiology
Risk Factors
Tuberculosis, Pulmonary* / complications
Tuberculosis, Pulmonary* / epidemiology
Venous Thromboembolism* / epidemiology

Substances

Anticoagulants